Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-10

Clinical Trial Update: Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

View source ↗

Summary

Real-life study evaluating dolutegravir plus lamivudine in treatment-naive adults with HIV-1 infection. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)
  • Lamivudine (lamivudine)

Snippet

Sponsor: University Hospital Virgen de las Nieves | Conditions: HIV-1-infection | Status: COMPLETED